Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy
Journal of the American Heart Association · 15.07.2025 · 14 (14)
DOI: 10.1161/jaha.124.040415 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 15.07.2025. Verfasst von Mahdi S Agha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine Wake Forest University School of Medicine Winston-Salem NC USA. Hauptthemen laut MEDLINE: Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists, Adrenergic beta-Antagonists, Cardiomyopathies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
High right ventricular pacing burden can result in pacing‐induced cardiomyopathy (PICM). The goal of this study was to investigate whether angiotensin‐converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and β‐blockers (BB) are associated with a reduction in risk of PICM in patients with high right ventricular pacing burden.
Methods
This was a single‐center, retrospective study that included patients with normal ejection fraction and complete heart block who underwent pacemaker implantation. The medical therapy group included patients who received ACEI/ARB, BB, or both. The control group received neither ACEI/ARB nor BB. The primary end point was PICM, defined as upgrade to a biventricular device or reduction in ejection fraction to ≤40% without another cause identified. Fine‐Gray subdistribution hazard models were used to determine the relationship between medical therapy and cumulative incidence of PICM.
Results
The study included 642 patients (mean±SD age, 71±14 years; 51% women). Over 10 years of follow‐up, 76 (11.8%) received ACEI/ARB only; 49 (7.6%) received BB only, and 86 (13.4%) received both. PICM occurred in 10 of 211 in the medical therapy group (4.7%) and in 30 of 431 in the control group (7.0%). In adjusted weighted analyses, the risk of PICM was significantly lower in the medical therapy group compared with the control group (hazard ratio [HR], 0.59 [95% CI, 0.45–0.77]). Patients on combination therapy had the lowest risk (HR, 0.46 [95% CI, 0.31–0.69]).
Conclusions
Patients with high right ventricular pacing burden who received ACEI, ARB, or BB within 10 years of pacemaker implantation had a lower incidence of PICM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Medicine Wake Forest University School of Medicine Winston-Salem NC USA.
- Wake Forest University School of Medicine, Hypertension and Vascular Research Center Winston-Salem NC USA.
ORCID-Profile: Mahdi S Agha, Christopher L Schaich, Rishi Rikhi, Krupal Hari, Prashant Bhave
Zitieren
APA
Agha, M. S., Schaich, C. L., Rikhi, R., Hari, K., Bodziock, G., & Bhave, P. (2025). Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy. Journal of the American Heart Association, 14(14). https://doi.org/10.1161/jaha.124.040415
Vancouver
Agha MS, Schaich CL, Rikhi R, Hari K, Bodziock G, Bhave P. Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy. Journal of the American Heart Association. 2025;14(14). doi:10.1161/jaha.124.040415
BibTeX
@article{Agha2025,
author = {Agha, Mahdi S and Schaich, Christopher L and Rikhi, Rishi and Hari, Krupal and Bodziock, George and Bhave, Prashant},
title = {Effect of Medical Therapy on Reducing the Risk of Pacing‐Induced Cardiomyopathy},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {14},
doi = {10.1161/jaha.124.040415}
}
EUVIMED